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ERK Activation Propagates in Epithelial
Cell Sheets and Regulates Their
Migration during Wound Healing
cells did not significantly move forward (Figure 1A).
These results suggest the existence of a mechanism
that regulates mass migration of epithelial cells as a
unit. This is consistent with a previous finding that during
wound healing of MDCK cell sheets not only the wound
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Kyoto 606-8502 margin cells but also several rows of the submarginal
cells have the potency to move forward themselves [1].Japan
Two Waves of ERK Activation after WoundingSummary
Both in vivo and in vitro, epithelial wound is known to
induce a multitude of cellular responses, such as propa-In epithelial cell movements, which occur during
gation of calcium wave, activation of MAP kinases, andwound healing or embryonic morphogenesis, sheets
induction of gene expression around the wound [2, 6–9].of cells move together as a unit [1, 2]. Molecular mech-
However, it is still not understood how these responsesanisms that regulate this sheet movement have been
lead to coordinated migration of cell sheets as a unit.largely unknown, although cell locomotion or move-
To address this point, we focused on the ERK1/2-typement mechanisms for individual cells, such as for fi-
MAP kinase. ERK1/2 was reported to contribute to epi-broblastic cells, have been extensively studied [3–5].
thelial wound healing through induction of cell prolifera-Here, we show that, during wound healing, sheets of
tion but not through induction of cell migration [6]. OnMDCK epithelial cells migrate coordinately as a unit,
the other hand, ERK1/2 was reported to be involved inand wound-induced activation of ERK MAP kinase
motility of individual cells [10, 11]. To investigate the(ERK1/2) propagates in cell sheets in accordance with
role of ERK1/2 in cell migration during wound healing,the cell sheet movement. Inhibition of ERK1/2 activa-
we first examined the activation pattern of ERK1/2. Intion by specific MEK inhibitors or by expressing domi-
MDCK cells, ERK1/2 was found to be activated in anant-negative ERK2 results in marked inhibition of the
remarkable “two wave” fashion after wounding: a rapidsheet movement during wound healing, and inhibition
and transient activation (the “first wave”) and a slow andof the cell sheet movement by disrupting actin cy-
sustained activation that propagates from the woundtoskeleton suppresses propagation of ERK1/2 activa-
margin to the submarginal cells (the “second wave”)tion. These results indicate that cell movement and
(Figures 2A and 2B). Both the cell sheet migration andERK1/2 activation form a positive feedback loop,
the propagation of the second wave started immediatelywhich facilitates cell sheet migration. Moreover, we
after wounding and continued at almost constant ratesfind that Src family kinase inhibitors suppress both
(Figures 1B and 2B). During the propagation of the sec-cell migration and propagation of ERK1/2 activation,
ond wave, there was a remarkable correlation betweensuggesting that Src family kinase may participate in
ERK1/2 activation and cell motility: those cells that hadthis feedback loop. Interestingly, neither cell sheet mi-
higher concentrations of phosphorylated ERK1/2 showedgration as a unit nor migration-dependent propagation
a higher motility, which reflected in an elongated cellof ERK1/2 activation occurs during wound healing in
shape (Figure 2C). Moreover, once the opposing edgesfibroblastic 3Y1 cells. Thus, our results identify spe-
of the wound confronted one another, ERK1/2 was inac-cific requirements of ERK1/2 MAP kinase for epithelial
tivated around the closing edges of the wound, whilecell sheet movement.
ERK1/2 was still activated around the open wound (Fig-
ure 2D). Taken together, these results suggest that
Results and Discussion ERK1/2 is activated in those cells in a migratory phase.
These results suggest the involvement of ERK1/2 in cell
MDCK Cell Sheets Move Together as a Unit sheet motility during wound healing, contrary to the pre-
When a monolayer of MDCK epithelial cells was vious report [6]. We then examined the effect of inhibition
wounded, not only cells at the wound margin but also of ERK1/2 activation on cell sheet movement. Treatment
submarginal ones migrated coordinately into the wound, of cells with each of specific MEK inhibitors, U0126 or
and moving cells showed an elongated shape (Figures PD98059, which inhibited ERK1/2 activation (Figure 3A
1A and 1B). The marked increase in the number of the and data not shown), resulted in marked reduction (by
cells seen in a fixed area after wounding clearly indicates about 50%, p  0.01 by Student’s t test) of the rate of
that substantial populations of the submarginal cells cell sheet migration after wounding (Figures 3B and 3D,
moved forward (Figure 1A). Cell proliferation, which sel- left). Since U0126 and PD98059 are known to inhibit not
dom occurred during wound healing, did not contribute only ERK1/2 but also another ERK MAP kinase ERK5
significantly to the cell sheet migration. For a monolayer [12], we expressed ERK2 (KR), a kinase-dead, dominant-
of 3Y1 fibroblasts after wounding, while marginal cells negative mutant of ERK2, which specifically inhibited
actively moved and protruded lamellipodia, submarginal ERK1/2 activation [12] (data not shown). In all MDCK
clones (B2, 3, 6, and 9) that stably express ERK2 (KR),
the rate of cell sheet migration was significantly reduced*Correspondence to: l50174@sakura.kudpc.kyoto-u.ac.jp
Current Biology
732
treatment, which inhibited both the first and second
waves of ERK1/2 activation (see Figure 3A).
Src Family Kinase and Actin Cytoskeleton
Are Required for the Second Wave of ERK
Activation and Cell Sheet Migration
We then addressed the activation mechanism for
ERK1/2 after wounding of MDCK cells. As shown in
Figure 4A, ERK1/2 activation occurred even in the ab-
sence of serum, suggesting that growth factor stimula-
tion is not required for the activation of ERK1/2 after
wounding (Figure 4A). Neither cycloheximide nor actino-
mycin D inhibited ERK1/2 activation, suggesting that
neither protein neosynthesis nor new transcription is
required for the activation (Figure 4A). Next, we tested
a wide range of inhibitors for their ability to prevent ERK
activation. Remarkably, two types of inhibitors were
found to specifically inhibit the second wave of ERK1/2
activation: one is Src family kinase inhibitors (PP1 and
PP2) and the other actin inhibitors (cytochalasin D and
latrunculin B) (Figure 4A). Src family kinase inhibitors
PP1 and PP2 inhibited almost completely the second
wave of ERK activation but not the first wave of activa-
tion (Figure 4A), and they blocked the cell sheet move-
ment during wound healing almost completely (Figure
4B). PP3, an inactive analog of PP2, had no effect (Figure
4A). This result also supports our idea that the second
wave of ERK1/2 activation is important for cell sheet
movement. A recent report has shown that during HGF-
induced spreading of split cells, Src phosphorylation of
paxillin induces activation of ERK1/2 at focal complexesFigure 1. MDCK Cell Sheets Move Together as a Unit
[14]. Thus, Src family kinase may lie upstream of ERK1/2(A) Time-lapse microscopy of in vitro wound healing assay using
activation in our MDCK cell system. Two actin inhibitors,MDCK cells (left) or 3Y1 cells (right). The number of the cells seen
in a fixed area shown is indicated at the bottom of each panel. cytochalasin D and latrunculin B, which completely
(B) Quantification of MDCK cell sheet migration. The distance that blocked cell migration and cell sheet movement (Figure
the wound margin advanced was measured and plotted against 4B and data not shown), also inhibited specifically the
time (see the Supplemental Experimental Procedures at http://
second wave of ERK1/2 activation (Figure 4A). In con-www.current-biology.com/content/supplemental). Shown is the
trast, microtubule inhibitors nocodazole or taxol, whichmean  standard deviation from nine experiments.
did not block cell sheet movement (data not shown), did
not inhibit ERK1/2 activation (Figure 4A). These results
suggest the existence of a positive feedback loop be-
compared to that in control wild-type ERK2-expressing
tween the cell sheet movement and the second wave
clones (A1, 4, and 11) (Figure 3E). These results indicate
of ERK1/2 activation. Recent studies have demon-
that ERK1/2 is essential for proper migration of MDCK
strated that mechanical stretch is able to induce ERK1/2
cell sheets during wound healing. In 3Y1 fibroblastic
activation [15–17]. We can speculate that mechanical
cells, only the first wave of ERK1/2 activation was ob-
tension, which is induced by neighboring cell movement,
served after wounding (Figure 2A). A similar result was
leads to activation of ERK1/2, which in turn facilitates
reported for rat embryo fibroblasts [13]. Inhibition of this cell movement. The propagation of the second wave of
ERK1/2 activation by U0126 did not significantly affect ERK1/2 activation thus may occur through this positive
the movement of wound margin 3Y1 cells (a migration feedback loop. Src family kinase may participate in this
rate of U0126-treated cells was 81% 15% of the con- loop. In summary, our results identify a novel feedback
trol; 100%  4%; p  0.1 by Student’s t test). Because loop, consisting of the cell movement and the propaga-
neither the second wave of ERK1/2 activation nor cell tion of ERK1/2 activation, that regulates cell sheet mi-
sheet movement as a unit was observed in fibroblastic gration.
cells and because the second wave of ERK1/2 activation
paralleled the mass migration of cell sheet in MDCK Supplemental Data
epithelial cells (see Figures 1B and 2B–2D), the second, Supplemental Experimental Procedures are available online at
http://www.current-biology.com/content/supplemental.slow ERK1/2 activation appeared to be important for
regulating the MDCK cell sheet migration. This was the
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Figure 2. Two Waves of ERK Activation in MDCK Cell Sheets
(A) ERK1/2 activation in MDCK and 3Y1 cells. Cells were fixed without wounding (w/o) or fixed after wounding at each time point indicated
and stained with anti-phospho ERK1/2 antibody. The wound is at the top of each panel.
(B) Quantification of the data from the experiment with MDCK cells shown in (A). The distance that the waves of ERK1/2 activation propagated
was measured and plotted against time (see Supplemental Experimental Procedures on Current Biology’s website). At each time point, two
fields (880  691 m) were examined. Shown are the mean values  standard deviation of the data from the two images. At 3 min, 5 min,
and the time points later than 4 hr, we could not precisely measure the distance, since the waves extended outside the photographed areas.
(C) Correlation between the ERK1/2 activation and the cell shape change. MDCK cells were fixed and stained 2 hr after wounding. Fluorescence
and phase contrast images of the same field are shown. Cell elongation was quantified by measuring the cell area. While the average area
of activated ERK1/2-negative cells (inside the red line) was 100  11, that of activated ERK1/2-positive cells (outside the red line) was 144 
29 (arbitrary unit). Shown is mean  standard deviation of the data from three photographed areas. n  168  238.
(D) Inactivation of ERK1/2 by wound closure. MDCK cells were fixed and stained 8 hr after wounding. Fluorescence and phase contrast
images of the same field are shown.
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Figure 3. ERK1/2 Is Required for Migration of MDCK Cell Sheets
(A) U0126 blocks activation of ERK1/2. MDCK cells were pretreated with DMSO (DMSO) or 20 M U0126 (U0126). Cells were fixed without
wounding (w/o) or fixed after wounding at each time point indicated and stained with anti-phospho ERK1/2 antibody. The wound is at the
top of each panel.
(B) U0126 inhibits MDCK cell sheet migration. MDCK cells were pretreated with DMSO (DMSO) or 20 M U0126 (U0126). Time-lapse microscopy
of cell migration was performed for 6 hr after wounding.
(C) Diagram showing the scheme of measurement of cell sheet migration. The gray area was quantified.
(D) Effect of MEK inhibitors. (Left) Migration of MDCK cell sheets for 6 hr after wounding was quantified. MDCK cells were pretreated with
DMSO (DMSO), 20 M U0126 (U), or 30 M PD98059 (PD). (Right) MDCK cells were pretreated with DMSO or 20 M U0126 (Pre), or DMSO
or 20 M U0126 was added to MDCK cells 30 min after wounding (Post). Migration of MDCK cell sheets for 6 hr after addition of DMSO or
U0126 was quantified.
(E) Migration of MDCK cell clones that stably express GFP, GFP-ERK2 (wt), or GFP-ERK2 (KR) for 6 hr after wounding. Upper panels show
the result of anti-GFP Western blotting for each clone.
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Figure 4. Src Family Kinase and Actin Cy-
toskeleton Are Required for the Second Wave
of ERK1/2 Activation and Cell Sheet Migration
(A) Effect of various inhibitors on wound-
induced ERK1/2 activation. MDCK cells were
fixed 3 min or 2 hr after wounding in the me-
dium with 10% FCS in the absence (Control)
or presence of various inhibitors and stained
with anti-phospho ERK1/2 antibody. In the
case of Serum, wounding was given in the
absence of FCS (Serum). CHX, protein syn-
thesis inhibitor cycloheximide (18 M); ActD,
translation inhibitor actinomycin D (0.32 M);
SB, p38 inhibitor SB203580 (20 M); SP, JNK
inhibitor SP600125 (20 M); BIM, PKC inhibi-
tor bisindolylmaleimide I (10 M); LY, PI3K
inhibitor LY294002 (100 M); Y, ROCK (Rho
kinase) inhibitor Y27632 (50 M); PP1, Src
family kinase inhibitor (10 M); PP2, Src fam-
ily kinase inhibitor (10 M); PP3, an inactive
analog of PP2 (10 M); Noc, microtubule in-
hibitor nocodazole (33 M); Tax, microtubule
inhibitor taxol (5 M); CytD, actin inhibitor cy-
tochalasin D (1 M); LatB, actin inhibitor la-
trunculin B (0.2 M). The wound is at the top
of each panel.
(B) Effect of PP1 or cytochalasin D on wound
healing. MDCK cells were pretreated with
DMSO (DMSO), 10 M PP1 (PP1), or 1 M
cytochalasin D (CytD). Time-lapse micros-
copy of cell migration was performed for 6 hr
after wounding.
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